PMGC Holdings Inc. (ELAB) stock
ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.83+0.06 (+2.17%)
Close on Oct 19, 2026Market cap $2.26MP/E –Yield –
PMGC gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
PMGC's gross profit for the twelve months ending Sep 30, 2026 was $1.32M. For fiscal 2025 it was $185.31K, down 83.7% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $185.31K | -83.7% |
| FY2023 | Dec 31, 2023 | $1.13M | +153.6% |
| FY2022 | Dec 31, 2022 | $447.31K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $601.44K | +670.8% |
| Q2 FY2026 | Jun 30, 2026 | $385.69K | -2.1% |
| Q1 FY2026 | Mar 31, 2026 | $230.47K | -47.5% |
| Q4 FY2025 | Dec 31, 2025 | $107.28K | -75.9% |
| Q3 FY2025 | Sep 30, 2025 | $78.03K | -83.1% |
| Q3 FY2024 | Sep 30, 2024 | $393.90K | +7.6% |
| Q2 FY2024 | Jun 30, 2024 | $439.25K | +110.8% |
| Q1 FY2024 | Mar 31, 2024 | $445.65K | +353.0% |
| Q4 FY2023 | Dec 31, 2023 | $461.70K | – |
| Q3 FY2023 | Sep 30, 2023 | $366.15K | -99.8% |
| Q2 FY2023 | Jun 30, 2023 | $208.35K | – |
| Q1 FY2023 | Mar 31, 2023 | $98.39K | – |
| Q4 FY2022 | Dec 31, 2022 | -$353.45M | – |
| Q3 FY2022 | Sep 30, 2022 | $237.69M | – |
See a number that looks wrong?